[By what means does the rheumatic patient with gastrointestinal risks fare best?].
Einecke
Dirk
D
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D018849:Controlled Clinical Trials as Topic; D052246:Cyclooxygenase 2 Inhibitors / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D016861:Cyclooxygenase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use*; D004008:Diclofenac / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use*; D000077613:Etoricoxib; D005767:Gastrointestinal Diseases / Q000139:chemically induced*; D005858:Germany; D006801:Humans; D009288:Naproxen / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D010003:Osteoarthritis / Q000188:drug therapy; D054328:Proton Pump Inhibitors; D011725:Pyridines / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use*; D012216:Rheumatic Diseases / Q000188:drug therapy*; D012307:Risk Factors; D013450:Sulfones / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use*; D014481:United States
D000894:Anti-Inflammatory Agents, Non-Steroidal; D052246:Cyclooxygenase 2 Inhibitors; D016861:Cyclooxygenase Inhibitors; D054328:Proton Pump Inhibitors; D011725:Pyridines; D013450:Sulfones; D004008:Diclofenac; D009288:Naproxen; D000077613:Etoricoxib